Current Options for Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma. Journal of Kidney Cancer, [S. l.], v. 9, n. 3, p. 29–40, 2022. DOI: 10.15586/jkcvhl.v9i3.243. Disponível em: https://mail.jkcvhl.com/~jkcvhlco/index.php/jkcvhl/article/view/243. Acesso em: 19 jan. 2026.